(Q28235853)

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Parkinsonism, dementia and vertical gaze palsy in a Guamanian with atypical neuroglial degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Progressive supranuclear palsy on Guam.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

J. Clifford Richardson and 50 years of progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Excessive dopamine neuron loss in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

The primate thalamus is a key target for brain dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

The auditory startle response in parkinsonism may reveal the extent but not type of pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Distinct pathological features of the gallyas- and tau-positive glia in the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Discrepancy between clinical and pathological diagnoses of CBD and PSP.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Tau protein and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

NIH conference. Alzheimer disease: clinical and biological heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Accuracy of clinical diagnosis of progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Progressive supranuclear palsy: a survey of the disease course.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Frontal presentation in progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Progressive supranuclear palsy-like phenotype associated with bilateral hypoxic-ischemic striopallidal lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Neurosyphilis presenting as progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Clinical grand round: a rapidly progressive pyramidal and extrapyramidal syndrome with a supranuclear gaze palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Primary antiphospholipid antibody syndrome masquerading as progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Supranuclear disturbances of ocular motility in Lytico-Bodig

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Progressive supranuclear palsy phenotype secondary to CADASIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

A neurovisceral storage disease with vertical supranuclear ophthalmoplegia, and its relationship to Niemann-Pick disease. A report of nine patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Procerus sign in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

A clinical rating scale for progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Progression of gait, speech and swallowing deficits in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Clinical outcomes of progressive supranuclear palsy and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Autopsy patterns for Parkinson's disease and related disorders in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

The syndrome of 'pure akinesia' and its relationship to progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Long lasting pure freezing of gait preceding progressive supranuclear palsy: a clinicopathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Primary progressive freezing gait: a syndrome with many causes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Blink reflex elicited by auditory stimulation in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Corticobasal syndrome with tau pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Pathologic heterogeneity in clinically diagnosed corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Glial localization of four-repeat tau in atypical progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Clinicopathological correlates in frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

The prevalence of Parkinson's disease in an area of North Tyneside in the North-East of England

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970042-0

7 January 2021

10.1016/S1474-4422(09)70042-0

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

19233037

1 reference

Consolidated OpenCitations Corpus – April 2017